Clinical trials
Completed Carcinoma, Hepatocellular trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UMC Utrecht | 3 |
| Bayer | 2 |
| Hoffmann-La Roche | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Boehringer Ingelheim | 1 |
| Boston Scientific Corporation | 1 |
| Bristol-Myers Squibb | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Exelixis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 22 |
| Liver Neoplasms | 5 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Stomach Neoplasms | 3 |
| Carcinoma, Renal Cell | 2 |
| Carcinoma, Transitional Cell | 2 |
| Neoplasm Metastasis | 2 |
| Urinary Bladder Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.